News

Pfizer loses attempt to force journals to reveal peer review comments

BMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39538.486389.DB (Published 03 April 2008) Cite this as: BMJ 2008;336:743
  1. Clare Dyer
  1. 1BMJ

    A US federal judge in Illinois has rejected a bid by the drug company Pfizer to force two leading medical journals to hand over confidential documents relating to peer review of studies on its cyclo-oxygenase-2 inhibitors valdecoxib (Bextra) and celecoxib (Celebrex).

    The company sought the documents from a number of journals, including the BMJ, to help it defend 3000 product liability lawsuits over alleged side effects of the two drugs.

    But the journals have strongly contested the move as a threat to the process of peer …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe